US4781601046 - JNJ - 853260 (XNYS)
JOHNSON & JOHNSON Acción
144,70 USD
Cotizaciones actuales de JOHNSON & JOHNSON
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NYSE |
JNJ
|
USD
|
21.12.2024 00:27
|
144,70 USD
| 143,58 USD | 0,78 % |
XETRA |
JNJ.DE
|
EUR
|
20.12.2024 17:35
|
138,94 EUR
| 139,12 EUR | -0,13 % |
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | -1,38 % | -6,95 % | -11,86 % | -2,72 % | -7,02 % | -0,93 % |
Profil de l'entreprise pour JOHNSON & JOHNSON Action
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Fonds investis
Les fonds suivants ont investi dans : JOHNSON & JOHNSON investi :
Fonds | Vol. en millions 11.885,14 | Part (%) 7,11 % |
Fonds | Vol. en millions 21.456,84 | Part (%) 5,88 % |
Fonds | Vol. en millions 1.867,23 | Part (%) 3,92 % |
Fonds | Vol. en millions 12.780,82 | Part (%) 3,89 % |
Fonds | Vol. en millions 8.737,62 | Part (%) 3,24 % |
Données de l'entreprise pour JOHNSON & JOHNSON Action
Nom JOHNSON & JOHNSON
Société Johnson & Johnson
Symbole JNJ
Site web https://www.jnj.com
Marché d'origine
NYSE
WKN 853260
ISIN US4781601046
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - General
PDG Mr. Joaquin Duato
Capitalisation boursière 366 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 131,9 T
Adresse One Johnson & Johnson Plaza, 08933 New Brunswick
Date d'introduction en bourse 2007-12-28
Dividendes de 'JOHNSON & JOHNSON'
Date ex-dividende | Dividende par action |
---|---|
26.11.2024 | 1,24 USD |
27.08.2024 | 1,24 USD |
20.05.2024 | 1,24 USD |
16.02.2024 | 1,19 USD |
20.11.2023 | 1,19 USD |
25.08.2023 | 1,19 USD |
22.05.2023 | 1,19 USD |
17.02.2023 | 1,13 USD |
21.11.2022 | 1,13 USD |
22.08.2022 | 1,13 USD |
Fractionnements d'actions
Date | Fractionnement |
---|---|
13.06.2001 | 2:1 |
12.06.1996 | 2:1 |
10.06.1992 | 2:1 |
11.05.1989 | 2:1 |
19.05.1981 | 3:1 |
18.05.1970 | 3:1 |
19.06.1967 | 3:1 |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | JNJ.F |
NYSE | JNJ |
XETRA | JNJ.DE |
Autres actions
Les investisseurs qui détiennent JOHNSON & JOHNSON ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.